EGFR-HER2 inhibitor PD153035, Purity ≥98%

Cat. No.: X23-10-ZQ1042

EGFR-HER2 inhibitor PD153035, Purity ≥98%

Synonym: 183322-45-4; PD153035 hydrochloride; N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride; PD-153035 hydrochloride; EGFR-HER2 inhibitor

  • MDL: MFCD01074805
  • CAS Number: 183322-45-4
  • Compound CID: 11246488
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
PD153035, soluble in DMSO and insoluble in ethanol and water, is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR and EGFR.
Molecular Weight
396.7
Molecular Formula
C16H14BrN3O2.HCl
Targets
EGFR: 5.2 pM (Ki); EGFR: 5.2 pM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 0.46 mg/mL (1.16 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
PD153035 can be used to inhibit EGFR tyrosine kinase in cancer research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.